Assessment of ARIA Sufficiency: Gimoti (metoclopramide nasal spray)

    Basic Details
    Approval Date
    Friday, June 19, 2020
    Original Posting Date
    Health Outcome(s)
    adverse central nervous system reactions
    tardive dyskinesia